Cargando…
Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
We investigated the plasma levels of tumor-specific cell-free DNA (cfDNA) in 17 stage I–II (early) and IV (advanced) non-small cell lung cancer (NSCLC) patients who underwent radiotherapy. Digital polymerase chain reaction (PCR) and targeted sequencing showed that total and tumor-specific cfDNA leve...
Autores principales: | Kageyama, Shun-ichiro, Nihei, Keiji, Karasawa, Katsuyuki, Sawada, Takeshi, Koizumi, Fumiaki, Yamaguchi, Shigeo, Kato, Shunsuke, Hojo, Hidehiro, Motegi, Atsuhi, Tsuchihara, Katsuya, Akimoto, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922403/ https://www.ncbi.nlm.nih.gov/pubmed/29721209 http://dx.doi.org/10.18632/oncotarget.25053 |
Ejemplares similares
-
Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients
por: Kageyama, Shun-Ichiro, et al.
Publicado: (2018) -
PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
por: Kageyama, Shun-ichiro, et al.
Publicado: (2020) -
Comprehensive screening for drugs that modify radiation-induced immune responses
por: Okumura, Masayuki, et al.
Publicado: (2022) -
Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak
por: Hojo, Hidehiro, et al.
Publicado: (2017) -
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways
por: Du, Junyan, et al.
Publicado: (2023)